Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology

SANTA CLARA, Calif., April 15, 2021  Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions. Resolution Bioscience complements and expands Agilent’s capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further... Read more

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

MINNEAPOLIS, April 14, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, for its therapeutic development pipeline. Bio-Techne is a global life sciences company providing... Read more

Agilent Named One of Singapore’s Best Employers

Company rises in rank from last year SINGAPORE, April 14, 2021  Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a leading Singapore-based newspaper. Specifically, Agilent is ranked among the top 100 companies and fifth out... Read more

PerkinElmer Provides First Quarter Update and Schedules Earnings Call for Tuesday, May 4, 2021

 Company also announces appointment of Steve Willoughby as vice president, investor relations WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 13, 2021– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of 98% and 90%, respectively, for the first quarter ended April 4, 2021. PerkinElmer’s... Read more

Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess

Abby is the next generation chemiluminescence Western protein analyzer and Stellar modules set the standard for fluorescence sensitivity MINNEAPOLIS, April 8, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that automates traditional Western blotting.  This latest addition to the Simple Western product family offers... Read more

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 29, 2021

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 29, 2021 WALTHAM, Mass., April 5, 2021 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2021 before the market opens on Thursday, April 29, 2021, and will hold... Read more

10x Genomics Puts Single Cell Analysis Within Reach of All With Low Throughput Gene Expression Kit

April 1, 2021 at 8:30 AM EDTPDF Version Along with recent release of CellPlex, product increases access through affordability PLEASANTON, Calif., April 01, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG) today announced the launch of its Chromium Single Cell Gene Expression Low Throughput (LT) Kit, a new offering designed to put the power of... Read more

Oxford Nanopore and Circulomics launch kits to enable routine sequencing of ultra-long fragments of DNA

Thu 25th March 2021 Results from developers on human samples — MinION (left) and PromethION (right) The Ultra-Long DNA Sequencing Kit, which has enabled read lengths of up to 4.2 Mb and maximises the quantity of ultra-long fragments, is now available in store. In combination with Circulomics Nanobind Kits, the Oxford Nanopore Ultra-Long DNA Sequencing Kit... Read more